Sunshine Biopharma, Inc. (SBFM)
NASDAQ: SBFM · Real-Time Price · USD
1.410
-0.030 (-2.08%)
At close: Aug 1, 2025, 4:00 PM
1.400
-0.010 (-0.71%)
After-hours: Aug 1, 2025, 6:23 PM EDT

Chimerix Stock Forecast

SBFM's stock price has decreased by -73.8% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Chimerix stock has a target of 15, which predicts a 963.83% increase from the current stock price of 1.41.

Price Target: $15.00 (+963.83%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$15$15$15$15
Change+963.83%+963.83%+963.83%+963.83%
* Price targets were last updated on Dec 5, 2024.

Analyst Ratings

According to 1 stock analyst, the rating for Chimerix is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingJun '25Jul '25
Strong Buy11
Buy00
Hold00
Sell00
Strong Sell00
Total11

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Aegis Capital
Aegis Capital
Strong Buy
Reiterates
$15
Strong BuyReiterates$15+963.83%Dec 5, 2024
Aegis Capital
Aegis Capital
Strong Buy
Initiates
$5,200
Strong BuyInitiates$5,200+368,694.33%Aug 7, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
46.11M
from 34.87M
Increased by 32.20%
Revenue Next Year
61.20M
from 46.11M
Increased by 32.74%
EPS This Year
-0.58
from -7.32
EPS Next Year
0.08
from -0.58
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
71.41K228.43K4.35M24.09M34.87M46.11M61.20M
Revenue Growth
238.10%219.88%1,802.41%454.42%44.75%32.20%32.74%
EPS
----351.35-7.32-0.580.08
EPS Growth
-------
Forward PE
------17.28
No. Analysts
-----33
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026
High47.5M63.0M
Avg46.1M61.2M
Low44.3M58.8M

Revenue Growth

Revenue Growth20252026
High
36.1%
36.6%
Avg
32.2%
32.7%
Low
27.0%
27.5%

EPS Forecast

EPS20252026
High-0.600.08
Avg-0.580.08
Low-0.560.08

EPS Growth

EPS Growth20252026
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.